- Home
- BCRX vs BDJ Comparison
BCRX vs BDJ Comparison
Compare BCRX & BDJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- BDJ
- Stock Information
- Founded
- BCRX 1986
- BDJ 2005
- Country
- BCRX United States
- BDJ United States
- Employees
- BCRX N/A
- BDJ N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- BDJ Finance Companies
- Sector
- BCRX Health Care
- BDJ Finance
- Exchange
- BCRX Nasdaq
- BDJ Nasdaq
- Market Cap
- BCRX 1.7B
- BDJ 1.5B
- IPO Year
- BCRX 1994
- BDJ N/A
- Fundamental
- Price
- BCRX $9.97
- BDJ $8.50
- Analyst Decision
- BCRX Buy
- BDJ
- Analyst Count
- BCRX 8
- BDJ 0
- Target Price
- BCRX $16.75
- BDJ N/A
- AVG Volume (30 Days)
- BCRX 5.9M
- BDJ 561.6K
- Earning Date
- BCRX 05-05-2025
- BDJ 01-01-0001
- Dividend Yield
- BCRX N/A
- BDJ 8.85%
- EPS Growth
- BCRX N/A
- BDJ N/A
- EPS
- BCRX N/A
- BDJ N/A
- Revenue
- BCRX $503,485,000.00
- BDJ N/A
- Revenue This Year
- BCRX $27.64
- BDJ N/A
- Revenue Next Year
- BCRX $13.42
- BDJ N/A
- P/E Ratio
- BCRX N/A
- BDJ N/A
- Revenue Growth
- BCRX 41.67
- BDJ N/A
- 52 Week Low
- BCRX $5.06
- BDJ $6.91
- 52 Week High
- BCRX $11.11
- BDJ $8.66
- Technical
- Relative Strength Index (RSI)
- BCRX 65.89
- BDJ 59.92
- Support Level
- BCRX $9.83
- BDJ $8.14
- Resistance Level
- BCRX $11.11
- BDJ $8.54
- Average True Range (ATR)
- BCRX 0.51
- BDJ 0.11
- MACD
- BCRX 0.20
- BDJ 0.05
- Stochastic Oscillator
- BCRX 68.33
- BDJ 92.86
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About BDJ Blackrock Enhanced Equity Dividend Trust
BlackRock Enhanced Equity Dividend Trust is a United States closed-end management investment company. Its investment objective is to seek current income and current gains, with a secondary objective of long-term capital appreciation.